Pioneers in the development and clinical validation of digital biomarkers
120+
Partner centers
1500+
Patients
350+
Healthcare professionals
10
Clinical studies
7
Countries
Making visible evolutions previously undetectable
Opening the path to more predictive, preventive and personalized medicine, where each patient becomes an actor in their health and each professional has reliable data to provide better care.
Mobile applications dedicated to patients
The smartphone becomes a health sensor: co-designed and tested with patients, our applications ensure home collection of high-frequency data, validating real life.
Cloud security and proprietary algorithms
Collected patient data is securely hosted then processed by our proprietary algorithms to produce digital biomarkers usable in routine care and clinical research.
Dashboards to support healthcare professionals
Access to patient data transferred in real-time, structured to optimize follow-up and support care teams in medical decision-making.
Digital biomarkers
Physiological and behavioral measurements collected by digital devices, transformed into objective data through algorithmic processing, validated for clinical use.
GPS Signal
Distance
Accelerometer
Movement
Gyroscope
Movement
Screen
Finger position
Camera
Facial expressions, motor functions
Microphone
Voice parameters
Neurology and immunology
Autoimmune and neuro-inflammatory neurological disorders, as well as psychiatric disorders.
Toutes nos aires thérapeutiques
Hematology, metabolic diseases & rare genetic diseases
Groups rare diseases related to blood, metabolic processes and genetic disorders.
Our solutions
We develop Software as a Medical Device (SaMD) tailored to the needs of each disease for complete and personalized monitoring.
MSCopilot
Multiple sclerosis
MSCopilot is a digital medical device designed for monitoring patients with multiple sclerosis (MS). Through a mobile application, patients perform self-assessments on functional tests measuring walking, manual dexterity and cognition. These tests provide objective data to better track the long-term progression of the disease, including outside of relapse periods. Results are visualized on a dashboard by healthcare professionals, enabling continuous monitoring and optimal treatment adjustment to improve MS management.
MyoSense 360
Myasthenia gravis
MyoSense 360 is a digital medical device* for patients with myasthenia gravis, enabling autonomous and precise monitoring of disease progression. Through a mobile application and a connected watch, patients collect data on physical activity, sleep and muscle function, providing digital biomarkers for remote monitoring. MyoSense enables detection of disease flares to prevent them and optimize therapeutic adjustments. This device complements traditional clinical evaluations, offering patients and healthcare professionals key information to improve disease management.
NMOSDCopilot
Neuromyelitis optica
NMOSDCopilot is a digital medical device* designed for remote monitoring of neuromyelitis optica (NMOSD) symptoms, a disease whose symptoms fluctuate frequently. Through a mobile application, patients perform self-assessments on functional tests such as walking, cognition, dexterity and visual function. NMOSDCopilot provides objective data to best reflect symptoms and their impacts, enabling precise monitoring and treatment adjustment. Results are visualized on a dashboard for healthcare professionals, offering continuous and improved disease monitoring.
ME&MG
Myasthenia gravis
ME&MG is a digital medical device* designed to help patients with myasthenia gravis track their disease progression, which is often highly fluctuating. Through a mobile application, patients perform self-assessments on their symptoms, providing objective data to best reflect the impact of the disease. These results are then visualized on a dashboard by healthcare professionals, enabling precise and real-time treatment adjustment to improve overall disease management.
MuCopilot
Cystic fibrosis
MuCopilot is an innovative digital medical device* for monitoring patients with cystic fibrosis. Through a mobile application, patients perform functional tests such as the 6-minute walk test and cough monitoring. This device helps improve care by facilitating telemedicine for patients whose disease is stable, complementing new treatments that have already transformed their lives. Results are visualized on a dashboard by healthcare professionals, enabling precise remote monitoring and treatment decision adjustment.
* Products under development and validation
They trust us
